Radiofrequency ablation versus percutaneous ethanol injection for hepatocellular carcinoma: A meta-analysis of randomized controlled trials

World Journal of Surgical Oncology

Volumn 13, Issue 1, 2015, Pages

  Yang, Biao ^a   Zan, Rui Yu ^a   Wang, Shi Yu ^b   Li, Xiang Lian ^a   Wei, Mao Ling ^a   Guo, Wen Hao ^a   You, Xin ^a   Li, Jing ^a   Liao, Zheng Yin ^a  

^a SICHUAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ethanol injection; Hepatocellular carcinoma; Meta analysis; Radiofrequency ablation

Indexed keywords

ALCOHOL; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; ASCITES; BURN; CANCER RECURRENCE; CANCER SURVIVAL; CONSERVATIVE TREATMENT; FEVER; HEMATOMA; HEMATOTHORAX; HUMAN; HYDROTHORAX; INTERMETHOD COMPARISON; JAUNDICE; LIVER ABSCESS; LIVER CELL CARCINOMA; META ANALYSIS; OVERALL SURVIVAL; PERCUTANEOUS ETHANOL INJECTION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PAIN; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STOMACH HEMORRHAGE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMPARATIVE STUDY; INJECTION; LIVER NEOPLASMS; PROGNOSIS;

ANTI-INFECTIVE AGENTS, LOCAL; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; ETHANOL; HUMANS; INJECTIONS; LIVER NEOPLASMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84928735750     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/s12957-015-0516-7     Document Type: Article

References (50)

1. Forner A, Bruix J. Hepatocellular carcinoma-authors' reply. Lancet. 2012;380:470-1.
2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745-50.
3. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet. 1997;350:1142-3.
4. Okuda K. Primary liver cancers in Japan. Cancer. 1980;45:2663-9.
5. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40:225-35.
6. Bruix J, Sherman M. Practice Guidelines Committee AAftSoLD. Manag Hepatocell Carcinoma Hepatol. 2005;42:1208-12036.
7. Dusheiko G, Burroughs A, Hobbs K, Dick R. Treatment of small hepatocellular carcinomas. Lancet. 1992;340:285-8.
8. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52:iii1-8.
9. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-17.
10. Colombo M, Sangiovanni A. The European approach to hepatocellular carcinoma. Hepatogastroenterology. 2002;49:12-6.
11. Surman OS, Hertl M. Liver donation: donor safety comes first. Lancet. 2003;362:674-5.
12. Singer PA, Siegler M, Whitington PF, Lantos JD, Emond JC, Thistlethwaite JR, et al. Ethics of liver transplantation with living donors. N Engl J Med. 1989;321:620-2.
13. Sugiura N, Takara K, Ohto M, Okuda K, Hirooka N. Treatment of small hepatocellular carcinoma by percutaneous injection of ethanol into tumor with real-time ultrasound monitoring. Acta Hepatol Jpn. 1983;24:920.
14. Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 2009;49:453-9.
15. Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40:1352-60.
16. Giorgio A. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis: a simple, effective and cheap procedure for percutaneous ablation. J Gastrointestin Liver Dis. 2010;19:461-7.
17. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol. 1993;160:1023-8.
18. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology. 2010;78 Suppl 1:113-24.
19. Ishikawa T. Strategy for improving survival and reducing recurrence of HCV-related hepatocellular carcinoma. World J Gastroenterol. 2013;19:6127-30.
20. Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004;239:450-8.
21. Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: current status. World J Radiol. 2010;2:417-24.
22. Chiou YY, Chou YH. Radiofrequency ablation of hepatocellular carcinoma. J Med Ultrasound. 2008;16:272-84.
23. Bruix J, Sherman M. American Association for the Study of Liver D. Manag Hepatocell Carcinoma. 2011;53:1020-2.
24. Bouza C, Lopez-Cuadrado T, Alcazar R, Saz-Parkinson Z, Amate JM. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol. 2009;9:31.
25. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma =4 cm. Gastroenterology. 2004;127:1714-23.
26. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut. 2005;54:1151-6.
27. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122-30.
28. Xue-Wen W, Sen Y, Zhao L, Xiao-Fei H. Clinical effect of radiofrequency ablation therapy and percutaneous ethanol injection therapy on small hepatocellular carcinoma. Med J West China. 2011;23:1671-3.
29. Signoriello S, Annunziata A, Lama N, Signoriello G, Chiodini P, De Sio I, et al. Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. ScientificWorldJournal. 2012;2012:564706.
30. Brunello F, Veltri A, Carucci P, Pagano E, Ciccone G, Moretto P, et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol. 2008;43:727-35.
31. Giorgio A, Di Sarno A, De Stefano G, Scognamiglio U, Farella N, Mariniello A, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial. Anticancer Res. 2011;31:2291-5.
32. Forner A, Bruix J. Ablation for hepatocellular carcinoma: is there need to have a winning technique? J Hepatol. 2010;52:310-2.
33. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions 1. Radiology. 2000;214:761-8.
34. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.0. 2 [updated September 2009]. The Cochrane Collaboration 2009. 2010.
35. Parmar MKB. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-34.
36. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
37. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-101.
38. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
39. Azab M, Zaki S, El-Shetey AG, Abdel-Moty MF, Alnoomani NM, Gomaa AA, et al. Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma. Arab J Gastroenterol. 2011;12:113-8.
40. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection 1. Radiology. 2003;228:235-40.
41. Orlando A, Leandro G, Olivo M, Andriulli A, Cottone M. Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:514-24.
42. Salhab M, Canelo R. An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis. J Cancer Res Ther. 2011;7:463-75.
43. Shen A, Zhang H, Tang C, Chen Y, Wang Y, Zhang C, et al. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm. J Gastroenterol Hepatol. 2013;28:793-800.
44. Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgro G, Burroughs AK. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J Hepatol. 2010;52:380-8.
45. Weis S, Franke A, Mössner J, Jakobsen JC, Schoppmeyer K. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev. 2013;12:CD003046.
46. Dong W, Zhang T, Wang ZG, Liu H. Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol. 2014;20:10174-82.
47. Xu RH, Gao W, Wang C, Guo DK, Tang L, Zhang H, et al. Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis. Eur J Med Res. 2014;19:39.
48. Lopez PM, Villanueva A, Llovet JM. Systematic review: evidence-based management of hepatocellular carcinoma-an updated analysis of randomized controlled trials. Aliment Pharmacol Ther. 2006;23:1535-47.
49. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol. 2005;43:458-64.
50. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336:601.